Notch3 is required for arterial identity and maturation of vascular smooth muscle cells

Genes and Development

Volumn 18, Issue 22, 2004, Pages 2730-2735

  Domenga, Valérie ^a   Fardoux, Peggy ^a   Lacombe, Pierre ^a   Monet, Marie ^a   Maciazek, Jacqueline ^a   Krebs, Luke T ^b   Klonjkowski, Bernard ^c   Berrou, Eliane ^d   Mericskay, Matthias ^e   Li, Zhen ^e   Tournier Lasserve, Elisabeth ^a,e   Gridley, Thomas ^b   Joutel, Anne ^a,e  

^a INSERM   (France)

^b JACKSON LABORATORY   (United States)

^c Healthy Pigs Production and Experimentation Section   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Artery; Differentiation; Notch3; Smooth muscle cell

Indexed keywords

NOTCH3 RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTERY; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; ENDOTHELIUM CELL; MOUSE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; REGULATORY MECHANISM; VASCULAR SMOOTH MUSCLE;

ACTINS; ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CELL DIFFERENTIATION; CELLS, CULTURED; DESMIN; ENDOTHELIAL CELLS; HOMOZYGOTE; HUMANS; IN SITU HYBRIDIZATION; LAC OPERON; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, NOTCH; SWINE;

ANIMALIA; MAMMALIA;

EID: 8644219667     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.308904     Document Type: Article

References (26)

1. Artavanis-Tsakonas, S., Rand, M.D., and Lake, R.J. 1999. Notch signaling: Cell fate control and signal integration in development. Science 284: 770-776.
2. Berrou, E. and Bryckaert, M. 2001. Platelet-derived growth factor inhibits smooth muscle cell adhesion to fibronectin by ERK-dependent and ERK-independent pathways. J. Biol. Chem. 276: 39303-39309.
3. Bonvento, G., Charbonne, R., Correze, J.L., Borredon, J., Seylaz, J., and Lacombe, P. 1994. Is α-chloralose plus halothane induction a suitable anesthetic regimen for cerebrovascular research? Brain Res. 665: 213-221.
4. Carmeliet, P. 2003. Angiogenesis in health and disease. Nat. Med. 9: 653-660.
5. Chartier, C., Degryse, E., Gantzer, M., Dieterle, A., Pavirani, A., and Mehtali, M. 1996. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70: 4805-4810.
6. Davis, M.J. and Hill, M.A. 1999. Signaling mechanisms underlying the vascular myogenic response. Physiol. Rev. 79: 387-423.
7. Fischer, A., Schumacher, N., Maier, M., Sendtner, M., and Gessler, M. 2004. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes & Dev. 18: 901-911.
8. Iso, T., Kedes, L., and Hamamori, Y. 2003. HES and HERP families: Multiple effectors of the Notch signaling pathway. J. Cell Physiol. 194: 237-255.
9. Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cecillion, M., Marechal, E., et al. 1996. Notch3 mutations in CADASIL, an hereditary adult-onset condition causing stroke and dementia. Nature 383: 707-710.
10. Joutel, A., Andreux, F., Gaulis, S., Domenga, V., Cecillon, M., Battail, N., Piga, N., Chapon, F., Godfrain, C., and Tournier-Lasserve, E. 2000. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J. Clin. Invest. 105: 597-605.
11. Krebs, L.T., Xue, Y., Norton, C.R., Shutter, J.R., Maguire, M., Sundberg, J.P., Gallahan, D., Closson, V., Kitajewski, J., Callahan, R., et al. 2000. Notch signaling is essential for vascular morphogenesis in mice. Genes & Dev. 14: 1343-1352.
12. Krebs, L.T., Xue, Y., Norton, C.R., Sundberg, J.P., Beatus, P., Lendahl, U., Joutel, A., and Gridley, T. 2003. Characterization of Notch3-deficient mice: Normal embryonic development and absence of genetic interactions with a Notch1 mutation. Genesis 37: 139-143.
13. Lawson, N.D. and Weinstein, B.M. 2002. Arteries and veins: Making a difference with zebrafish. Nat. Rev. Genet. 3: 674-682.
14. Lawson, N.D., Scheer, N., Pham, V.N., Kim, C.H., Chitnis, A.B., Campos-Ortega, J.A., and Weinstein, B.M. 2001. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128: 3675-3683.
15. Li, L., Miano, J.M., Cserjesi, P., and Olson, E.N. 1996. SM22 α, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ. Res. 78: 188-195.
16. Moessler, H., Mericskay, M., Li, Z., Nagl, S., Paulin, D., and Small, J.V. 1996. The SM22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development 122: 2415-2425.
17. Moyon, D., Pardanaud, L., Yuan, L., Breant, C., and Eichmann, A. 2001. Plasticity of endothelial cells during arterial-venous differentiation in the avian embryo. Development 128: 3359-3370.
18. Mukouyama, Y.S., Shin, D., Britsch, S., Taniguchi, M., and Anderson, D.J. 2002. Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell 109: 693-705.
19. Owens, G.K. 1998. Molecular control of vascular smooth muscle cell differentiation. Acta Physiol. Scand. 164: 623-635.
20. Ruchoux, M.M., Guerouaou, D., Vandenhaute, B., Pruvo, J.P., Vermersch, P., and Leys, D. 1995. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol. (Berl) 89: 500-512.
21. Ruchoux, M.M., Domenga, V., Brulin, P., Maciazek, J., Limol, S., Tournier-Lasserve, E., and Joutel, A. 2003. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am. J. Pathol. 162: 329-342.
22. Shawber, C.J. and Kitajewski, J. 2004. Notch function in the vasculature: Insights from zebrafish, mouse and man. Bioessays 26: 225-234.
23. Tiemann, K., Weyer, D., Djoufack, P.C., Ghanem, A., Lewalter, T., Dreiner, U., Meyer, R., Grohe, C., and Fink, K.B. 2003. Increasing myocardial contraction and blood pressure in C57BL/6 mice during early postnatal development. Am. J. Physiol. Heart Circ. Physiol. 284: H464-H474.
24. van der Loop, F.T., Gabbiani, G., Kohnen, G., Ramaekers, F.C., and van Eys, G.J. 1997. Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler. Thromb. Vasc. Biol. 17: 665-671.
25. Wang, H.U., Chen, Z.F., and Anderson, D.J. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93: 741-753.
26. Xue, Y., Gao, X., Lindsell, C.E., Norton, C.R., Chang, B., Hicks, C., Gendron-Maguire, M., Rand, E.B., Weinmaster, G., and Gridley, T. 1999. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 8: 723-730.